ModivCare (NASDAQ:MODV) vs. TODOS MED (OTCMKTS:TOMDF) Financial Survey

ModivCare (NASDAQ:MODV) and TODOS MED (OTCMKTS:TOMDF) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk and analyst recommendations.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for ModivCare and TODOS MED, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ModivCare	0	3	1	0	2.25
TODOS MED	0	0	0	0	0.00

ModivCare presently has a consensus price target of $8.38, indicating a potential upside of 171.92%. Given ModivCare’s stronger consensus rating and higher probable upside, analysts plainly believe ModivCare is more favorable than TODOS MED.

Valuation and Earnings

This table compares ModivCare and TODOS MED”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ModivCare	$2.75 billion	0.02	-$201.28 million	($16.10)	-0.19
TODOS MED	N/A	N/A	N/A	N/A	N/A

TODOS MED has lower revenue, but higher earnings than ModivCare.

Risk and Volatility

ModivCare has a beta of 1.27, indicating that its share price is 27% more volatile than the S&P 500. Comparatively, TODOS MED has a beta of -0.03, indicating that its share price is 103% less volatile than the S&P 500.

Profitability

This table compares ModivCare and TODOS MED’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ModivCare	-8.33%	13.64%	-1.19%
TODOS MED	N/A	N/A	N/A

Summary

ModivCare beats TODOS MED on 6 of the 8 factors compared between the two stocks.

About ModivCare

ModivCare Inc., a technology-enabled healthcare services company, provides a suite of integrated supportive care solutions for public and private payors and their members. The company operates through four segments: Non-Emergency Medical Transportation (NEMT), Personal Care, Remote Patient Monitoring (RPM), and Corporate and Other. The company offers risk underwriting, contact center management, network credentialing, claims management, and non-emergency medical transport management services for Medicaid or Medicare eligible members, whose limited mobility or financial resources hinder their ability to access necessary healthcare and social services. It also provides in-home personal care services, such as bathing, personal hygiene, grooming, oral care, dressing, medication reminders, meal planning, preparation and feeding, housekeeping, transportation services, prescription reminders, and assistance with dressing and ambulation services through placing non-medical personal care assistants, home health aides, and skilled nurses primarily to Medicaid patients in need of care monitoring and assistance in performing daily living activities, including senior citizens and disabled adults. In addition, the company offers remote patient monitoring solutions, including personal emergency response systems, vitals monitoring, medication management, and data-driven patient engagement solutions. It serves federal, state, and local government agencies, MCOs, commercial insurers, private individuals, and health systems. The company was formerly known as The Providence Service Corporation and changed its name to ModivCare Inc. in January 2021. ModivCare Inc. was incorporated in 1996 and is headquartered in Denver, Colorado.

About TODOS MED

Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.